Immediate Impact
32 standout
Citing Papers
Diabetic neuropathy: cutting-edge research and future directions
2025 Standout
Prunin: An Emerging Anticancer Flavonoid
2025 Standout
Works of Sybille Baumann being referenced
First‐in‐human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics
2022
Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sybille Baumann | 29 | 73 | 22 | 36 | 10 | 143 | |
| Giulia Mazzitelli | 56 | 56 | 45 | 53 | 11 | 215 | |
| Barbara Tamowicz | 21 | 10 | 9 | 10 | 11 | 176 | |
| Marcelle F. Dunning | 25 | 63 | 27 | 21 | 11 | 185 | |
| Zoi Aidoni | 24 | 20 | 13 | 20 | 12 | 94 | |
| Jason Cupitt | 47 | 47 | 14 | 76 | 10 | 171 | |
| Dragan Kovačić | 20 | 50 | 96 | 37 | 7 | 183 | |
| N. Delvau | 14 | 30 | 21 | 8 | 13 | 206 | |
| Elisabetta Borciani | 30 | 28 | 13 | 23 | 9 | 141 | |
| Sophie West | 30 | 141 | 7 | 69 | 10 | 241 | |
| Anne Trontell | 20 | 71 | 11 | 37 | 10 | 192 |
All Works
Login with ORCID to disown or claim papers
Loading papers...